Source comparison
PT-141 Vial Size: Format Comparison
Choosing the right PT-141 vial size depends on your research timeline, dose frequency, and storage capabilities. The table below compares practical implications across the three standard formats. | Vial Size | Reconstitution Volume | Final Concentration | Dose
This comparison does not assign a generated winner or score.
- Choosing the right PT-141 vial size depends on your research timeline, dose frequency, and storage capabilities. The table below compares practical implications across the three standard formats.
- | Vial Size | Reconstitution Volume | Final Concentration | Doses Available (1mg each) | Shelf Life After Mixing | Best Use Case | Bottom Line ||—|—|—|—|—|—|| 2mg | 1mL bacteriostatic water | 2mg/mL | 2 doses | 28 days (minimal degradation if used within 7 days) | Pilot studies, single-subject trials, dose-finding protocols | Most expensive per milligram but eliminates waste. Ideal when protocol requires only 1–3 total administrations || 5mg | 1mL bacteriostatic water | 5mg/mL | 5 doses | 28 days | Short-term protocols (1–2 weeks), small research cohorts | Balanced option for 3–6 dose protocols. Mid-range cost per milligram with manageable waste if protocol ends early || 10mg | 2mL bacteriostatic water | 5mg/mL | 10 doses | 28 days (potency drops 3–9% by day 30) | Extended protocols, larger cohorts, repeat-dose studies | Lowest cost per milligram but requires disciplined storage and full protocol completion within stability window. Wasted peptide if fewer than 7 doses actually used |